Wolf Group Capital Advisors Sells 1,914 Shares of Encompass Health Corporation (NYSE:EHC)

Wolf Group Capital Advisors reduced its holdings in shares of Encompass Health Corporation (NYSE:EHC) by 17.5% in the first quarter, Holdings Channel.com reports. The fund owned 9,029 shares of the company’s stock after selling 1,914 shares during the quarter. Wolf Group Capital Advisors’ holdings in Encompass Health were worth $914,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Colonial Trust Co SC bought a new stake in shares of Encompass Health during the 4th quarter worth approximately $29,000. Transce3nd LLC bought a new stake in shares of Encompass Health during the 4th quarter worth approximately $40,000. CBIZ Investment Advisory Services LLC lifted its stake in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock worth $42,000 after acquiring an additional 127 shares during the last quarter. V Square Quantitative Management LLC lifted its stake in shares of Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after acquiring an additional 177 shares during the last quarter. Finally, Signaturefd LLC lifted its stake in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company’s stock worth $65,000 after acquiring an additional 125 shares during the last quarter. 97.25% of the stock is owned by institutional investors.

Insider Activity

In other news, EVP John Patrick Darby sold 10,000 shares of Encompass Health stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the transaction, the executive vice president now directly owns 79,710 shares in the company, valued at approximately $9,149,910.90. This trade represents a 11.15% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Mark J. Tarr sold 118,384 shares of Encompass Health stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the transaction, the chief executive officer now owns 527,070 shares in the company, valued at $64,054,817.10. This represents a 18.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 132,663 shares of company stock worth $16,034,082. 2.10% of the stock is currently owned by company insiders.

Encompass Health Trading Down 1.1%

Shares of NYSE:EHC opened at $119.18 on Wednesday. Encompass Health Corporation has a 12-month low of $82.74 and a 12-month high of $123.13. The business’s fifty day simple moving average is $114.79 and its 200-day simple moving average is $103.63. The company has a market capitalization of $12.01 billion, a PE ratio of 24.62, a P/E/G ratio of 2.45 and a beta of 0.89. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.81.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.19 by $0.18. Encompass Health had a return on equity of 17.63% and a net margin of 8.97%. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same period last year, the business posted $1.12 EPS. The business’s revenue was up 10.6% compared to the same quarter last year. As a group, equities research analysts predict that Encompass Health Corporation will post 4.8 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a $0.17 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.57%. Encompass Health’s dividend payout ratio is presently 14.05%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on EHC shares. KeyCorp lifted their target price on Encompass Health from $122.00 to $135.00 and gave the company an “overweight” rating in a research report on Tuesday, May 27th. Barclays lifted their target price on Encompass Health from $118.00 to $129.00 and gave the company an “overweight” rating in a research report on Friday, April 25th. Truist Financial reaffirmed a “buy” rating and set a $135.00 target price (up from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Stephens raised Encompass Health from an “overweight” rating to a “strong-buy” rating and set a $135.00 target price for the company in a research report on Thursday, June 5th. Finally, UBS Group lifted their target price on Encompass Health from $117.00 to $130.00 and gave the company a “buy” rating in a research report on Monday, April 28th. Eight investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, Encompass Health currently has a consensus rating of “Buy” and a consensus target price of $127.00.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.